Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 5
2005 5
2006 9
2007 9
2008 8
2009 9
2010 12
2011 18
2012 22
2013 18
2014 25
2015 29
2016 29
2017 27
2018 23
2019 18
2020 33
2021 40
2022 29
2023 21
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

357 results

Results by year

Filters applied: . Clear all
Page 1
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study).
Tzoumpa S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, El Aarbaoui T, Dereure O, Quereux G, Faiz S, de Vicq de Cumptich M, Ram-Wolff C, Janela-Lapert R, Guenova E, Lheure C, Le Corre Y, Adamski H, Blanchard M, Bonnet N, Amatore F, Grange F, Troin L, Bagot M, Beylot-Barry M. Tzoumpa S, et al. Among authors: bagot m. Br J Dermatol. 2024 Apr 25:ljae153. doi: 10.1093/bjd/ljae153. Online ahead of print. Br J Dermatol. 2024. PMID: 38660811 No abstract available.
Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study.
Mitsunaga K, Bagot M, Ram-Wolff C, Guenova E, von Gugelberg C, Hodak E, Amitay-Laish I, Papadavid E, Jonak C, Porkert S, Scarisbrick J, Applewaite R, Beylot-Barry M, Nicolay J, Quaglino P, Sanches JA, Cury-Martins J, Lora-Pablos D, Ortiz P. Mitsunaga K, et al. Among authors: bagot m. Br J Dermatol. 2024 Apr 10:ljae152. doi: 10.1093/bjd/ljae152. Online ahead of print. Br J Dermatol. 2024. PMID: 38596857
CD39 is expressed by a wide range of cutaneous T-cell lymphomas.
Battesti G, Thonnart N, Bozonnat A, Ram-Wolff C, de Masson A, Bensussan A, Bagot M, Marie-Cardine A, Battistella M. Battesti G, et al. Among authors: bagot m. Skin Health Dis. 2024 Jan 10;4(2):e334. doi: 10.1002/ski2.334. eCollection 2024 Apr. Skin Health Dis. 2024. PMID: 38577051 Free PMC article.
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
Roccuzzo G, Calvão J, Dobos G, Morsia E, Mozas P, Peterknecht E, Schrader AMR, Zottarelli F, Bagot M, Stadler R, Vermeer M, Quaglino P, Scarisbrick J. Roccuzzo G, et al. Among authors: bagot m. Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093/bjd/ljae145. Online ahead of print. Br J Dermatol. 2024. PMID: 38576352 No abstract available.
Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas.
Giustiniani J, Ta VA, Belkhelouat S, Battistella M, Ouahbi D, Ram-Wolff C, Louveau B, Mourah S, Bagot M, Moins-Teisserenc H, Ortonne N, Bensussan A, De Masson A. Giustiniani J, et al. Among authors: bagot m. J Invest Dermatol. 2024 Mar 28:S0022-202X(24)00259-8. doi: 10.1016/j.jid.2024.03.019. Online ahead of print. J Invest Dermatol. 2024. PMID: 38555062 Free article. No abstract available.
Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides.
Lazaridou I, Alqahtani M, Louveau B, Ram-Wolff C, Alharbi B, Al Hage J, Dumont M, Bouaziz JD, Bagot M, Moins-Teisserenc H, Rivet J, Battistella M, Mourah S, de Masson A. Lazaridou I, et al. Among authors: bagot m. J Eur Acad Dermatol Venereol. 2024 Mar 12. doi: 10.1111/jdv.19922. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38469982 No abstract available.
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
Knobler R, Geroldinger-Simić M, Kreuter A, Hunzelmann N, Moinzadeh P, Rongioletti F, Denton C, Mouthon L, Cutolo M, Smith V, Gabrielli A, Bagot M, Olesen AB, Foeldvari I, Jalili A, Kähäri VM, Kárpáti S, Kofoed K, Olszewska M, Panelius J, Quaglino P, Seneschal J, Sticherling M, Sunderkötter C, Tanew A, Wolf P, Worm M, Skrok A, Rudnicka L, Krieg T. Knobler R, et al. Among authors: bagot m. J Eur Acad Dermatol Venereol. 2024 Mar 8. doi: 10.1111/jdv.19937. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38456518
Two cases of dupilumab-responsive Kimura disease.
Battesti G, Jachiet M, Lepelletier C, Petit A, Vignon-Pennamen MD, Cassius C, de Masson A, Battistella M, Bagot M, Bouaziz JD, Mahévas T. Battesti G, et al. Among authors: bagot m. Clin Exp Dermatol. 2024 Apr 23;49(5):502-506. doi: 10.1093/ced/llad455. Clin Exp Dermatol. 2024. PMID: 38149974
A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom.
Assaf C, Illidge TM, Waser N, He M, Li T, Zomas A, Bent-Ennakhil N, Little M, Ortiz-Romero PL, Pimpinelli N, Dalal M, Bagot M. Assaf C, et al. Among authors: bagot m. Cancers (Basel). 2023 Nov 30;15(23):5669. doi: 10.3390/cancers15235669. Cancers (Basel). 2023. PMID: 38067371 Free PMC article.
357 results